Which statement reflects how BUDs relate to compounded prescriptions?

Prepare for the Curexa Certification Exam with engaging quizzes featuring flashcards and multiple choice questions. Enhance your understanding with detailed explanations for each question and ensure your readiness for exam success!

Multiple Choice

Which statement reflects how BUDs relate to compounded prescriptions?

Explanation:
Beyond-use dating is about how long a compounded preparation is expected to remain safe and effective after it’s made. For compounded medicines, the date isn’t fixed; it’s set by the pharmacist using stability data, the formulation type (nonaqueous, aqueous, sterile vs non-sterile), storage conditions, and the risk level of the compounding. When solid stability data exist, a longer BUD may be approved within those limits; if data are limited or absent, USP guidelines provide default BUDs based on the formulation. This means compounded prescriptions have BUDs determined by the compounding process, not a universal six months or the expiration date of commercial products, and not that they don’t have BUDs.

Beyond-use dating is about how long a compounded preparation is expected to remain safe and effective after it’s made. For compounded medicines, the date isn’t fixed; it’s set by the pharmacist using stability data, the formulation type (nonaqueous, aqueous, sterile vs non-sterile), storage conditions, and the risk level of the compounding. When solid stability data exist, a longer BUD may be approved within those limits; if data are limited or absent, USP guidelines provide default BUDs based on the formulation. This means compounded prescriptions have BUDs determined by the compounding process, not a universal six months or the expiration date of commercial products, and not that they don’t have BUDs.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy